Induced pluripotent stem cells share proteins with some cancers. The cells can be used as a vaccine to prevent pancreatic cancers in mice.
As risk factors such as no health insurance and low income accumulate, colorectal cancer patients are less likely to finish chemotherapy.
Stanford Medicine researchers discover that certain proteins can predict survival for patients with a type of eye cancer.
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
A cancer survivor treated at Stanford has written a book to help kids facing stem cell transplant understand the procedure and approach it with courage.
People who have their first colonoscopy between the age of 45 and 49 halve their risk of subsequent colorectal cancers, a Stanford Medicine study has found.
Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster …
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
In 2020, contributing editor Paul Costello’s top podcasts reflect the challenges of the coronavirus and other timely health care issues.
Stanford Medicine magazine's most-read articles of 2020 were about COVID-19, grieving and chemo brain, a misunderstood side effect of chemotherapy.
As younger adults are being diagnosed with colon cancer, the U.S. Preventive Services Task Force is recommending screening all adults older than 45.
ESPN told the story of Stanford football coach David Shaw donating stem cells to save his brother, who had a rare form of lymphoma.
Scientists have created an AI tool to help doctors more precisely choose colorectal cancer treatments that will work best on individual patients.
Stanford researchers studied whether there was any pattern linking patients' racial, ethnic or socioeconomic status with which treatment they received.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.